Publications
Adhikari N, Mariash A, McCue JD, Mullegama S, Helig C, Brosius F, Hall JL. A genetic approach to disssecting the role of glucose in vascular remodeling. Circulation 12(17);11-33:255, 2005.
Barton PJR, Felkin LE, Birks EJ, Cullen ME, Banner NR, Grindle S, Hall JL, Miller LW, Yacoub MH. Myocardial IGF-1 gene expression during recovery from heart failure following combined LVAD and clenbuterol therapy. Circulation 12 (suppl 9), I46-50, 2005.
Basi D, Adhikari N, Mariash A, Li Q, Kao E, Mullegama S, Hall JL. Femoral artery neointimal hyperplasia is reduced after wire injury in Ref-1 (+/-) mice. Epub Am J Physiol Heart and Circ.
Birks EJ, Hall JL, Barton PJR, Grindle S, Latif N, Hardy JP, Banner NR, Khaghani A, Miller LW, Yacoub MH.Gene profiling changes in cytoskeletal proteins during clinical recovery following left ventricular assist device (LVAD) support. Circulation 112(suppl 9), 2005.
Birks EJ, Hall JL, Barton PJR, Grindle S, Latif N, Hardy JP, Banner NR, Khaghani A, Miller LW, Yacoub MH.Gene profiling changes in cytoskeletal proteins during clinical recovery following left ventricular assist device (LVAD) support. Circulation 112(suppl 9), 2005.
Chen Y, Park S, Li Y, Missov E, Hou M, Han X, Hall JL, Miller LW, Bache RJ. Alterations of gene expression in the failing myocardium following left ventricular assist device support. Physiol Genomics 14:251-260, 2003.
Cullen ME, Yuen AH, Felkin LE, Smolenski RT, Hall JL, Grindle S, Miller LW, Birks EJ, Yacoub MH, Barton PJ.Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failue and normalized after recovery: potential implications for local creatine synthesis. Circulation 4:114(I Suppl):I16-20, 2006.
Guan Z, A Mariash, X Wang, Q Li, Hall JL. Redox factor 1 is a critical mediator governing NF-kB and A20 regulation in the vascular endothelium. Arterioscler Thromb Vasc Biol. 25:96-101, 2005.
Hall JL, Birks EJ, Rider J, Grindle S, Barton P, Mariash A, Charles N, Dyke DB, Pagoni F, Yacoub MH. Miller LW. Molecular signature of recovery following left ventricular assist device (LVAD) support(accepted for publication, Eur H J).
Hall JL, Grindle S, Han X, Fermin D, Park S, Chen Y, Bache RJ, Mariash A, Guan Z, Ormaza S, Thompson J, Graziano J, de Sam Lazaro S, Pan S, Simari RD, Miller LW. Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks. Physiol Genomics 17:283-291, 2004.
Hall JL, Gibbon GH, Chatham JC. IGF-I promotes a shift in metabolic flux in vascular smooth muscle cells. Am J Physiol Endocrinol Metab 283:E465-71, 2002.
Huang, X, Pan W, Park S, Han X, Chen Y, Miller LW, Hall JL. Modeling the relationship between LVAD support time and gene expression changes in the human heart by penalized partial least squares. Bioinformatics, 20(6):888-94, 2004.
Huebert RC, Li Q, Adhikari N, Charles NJ, Han X, Ezzat MK, Grindle S, Park S, Ormaza S, Fermin D, Miller LW, Hall JL. Identification and regulation of Sprouty1, a negative inhibitor of the ERK cascade, in the human heart. Physiological Genomics.18:284-289, 2004.
Kittleson MM, Ye SQ, Irizarry RA, Minhas KM, Edness G, Conte JV, Parmigiani G, Miller LW, Chen Y, Hall JL, Garcia JG, Hare JM. Identification of a gene expression profile that differentiates between ischemic and nonischemic cardiomyopathy. Circulation 110:3344-51, 2004.
Wang X, Li Q, Adhikari N, Hall JL. A role for muscle LIM protein (MLP) in vascular remodeling. J Mol Cell Cardiol. 40(4):503-9, 2006.
Wang X, Adhikari N, Li Q, Hall JL. The LDL receptor related protein LRP6 regulates proliferation and survival through the Wnt cascade in vascular smooth muscle cells. AJP Heart 287(6):H2376-H2383, 2004.
Wang XH, Adhikari N, Li Q, Mariash A, Guan Z, Hall JL. The role of beta-transducin repeat containing protein in the regulation of NF-kB in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 24:85-90, 2004.
Wang XH, Xiao Y, Zhao Y, Hall JL. A role for the beta-catenin and T cell factor 4 (Tcf-4) signaling cascade in vascular remodeling. Circ Res 90:340-7, 2002.
Barton PJR, Felkin LE, Birks EJ, Cullen ME, Banner NR, Grindle S, Hall JL, Miller LW, Yacoub MH. Myocardial IGF-1 gene expression during recovery from heart failure following combined LVAD and clenbuterol therapy. Circulation 12 (suppl 9), I46-50, 2005.
Basi D, Adhikari N, Mariash A, Li Q, Kao E, Mullegama S, Hall JL. Femoral artery neointimal hyperplasia is reduced after wire injury in Ref-1 (+/-) mice. Epub Am J Physiol Heart and Circ.
Birks EJ, Hall JL, Barton PJR, Grindle S, Latif N, Hardy JP, Banner NR, Khaghani A, Miller LW, Yacoub MH.Gene profiling changes in cytoskeletal proteins during clinical recovery following left ventricular assist device (LVAD) support. Circulation 112(suppl 9), 2005.
Birks EJ, Hall JL, Barton PJR, Grindle S, Latif N, Hardy JP, Banner NR, Khaghani A, Miller LW, Yacoub MH.Gene profiling changes in cytoskeletal proteins during clinical recovery following left ventricular assist device (LVAD) support. Circulation 112(suppl 9), 2005.
Chen Y, Park S, Li Y, Missov E, Hou M, Han X, Hall JL, Miller LW, Bache RJ. Alterations of gene expression in the failing myocardium following left ventricular assist device support. Physiol Genomics 14:251-260, 2003.
Cullen ME, Yuen AH, Felkin LE, Smolenski RT, Hall JL, Grindle S, Miller LW, Birks EJ, Yacoub MH, Barton PJ.Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failue and normalized after recovery: potential implications for local creatine synthesis. Circulation 4:114(I Suppl):I16-20, 2006.
Guan Z, A Mariash, X Wang, Q Li, Hall JL. Redox factor 1 is a critical mediator governing NF-kB and A20 regulation in the vascular endothelium. Arterioscler Thromb Vasc Biol. 25:96-101, 2005.
Hall JL, Birks EJ, Rider J, Grindle S, Barton P, Mariash A, Charles N, Dyke DB, Pagoni F, Yacoub MH. Miller LW. Molecular signature of recovery following left ventricular assist device (LVAD) support(accepted for publication, Eur H J).
Hall JL, Grindle S, Han X, Fermin D, Park S, Chen Y, Bache RJ, Mariash A, Guan Z, Ormaza S, Thompson J, Graziano J, de Sam Lazaro S, Pan S, Simari RD, Miller LW. Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks. Physiol Genomics 17:283-291, 2004.
Hall JL, Gibbon GH, Chatham JC. IGF-I promotes a shift in metabolic flux in vascular smooth muscle cells. Am J Physiol Endocrinol Metab 283:E465-71, 2002.
Huang, X, Pan W, Park S, Han X, Chen Y, Miller LW, Hall JL. Modeling the relationship between LVAD support time and gene expression changes in the human heart by penalized partial least squares. Bioinformatics, 20(6):888-94, 2004.
Huebert RC, Li Q, Adhikari N, Charles NJ, Han X, Ezzat MK, Grindle S, Park S, Ormaza S, Fermin D, Miller LW, Hall JL. Identification and regulation of Sprouty1, a negative inhibitor of the ERK cascade, in the human heart. Physiological Genomics.18:284-289, 2004.
Kittleson MM, Ye SQ, Irizarry RA, Minhas KM, Edness G, Conte JV, Parmigiani G, Miller LW, Chen Y, Hall JL, Garcia JG, Hare JM. Identification of a gene expression profile that differentiates between ischemic and nonischemic cardiomyopathy. Circulation 110:3344-51, 2004.
Wang X, Li Q, Adhikari N, Hall JL. A role for muscle LIM protein (MLP) in vascular remodeling. J Mol Cell Cardiol. 40(4):503-9, 2006.
Wang X, Adhikari N, Li Q, Hall JL. The LDL receptor related protein LRP6 regulates proliferation and survival through the Wnt cascade in vascular smooth muscle cells. AJP Heart 287(6):H2376-H2383, 2004.
Wang XH, Adhikari N, Li Q, Mariash A, Guan Z, Hall JL. The role of beta-transducin repeat containing protein in the regulation of NF-kB in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 24:85-90, 2004.
Wang XH, Xiao Y, Zhao Y, Hall JL. A role for the beta-catenin and T cell factor 4 (Tcf-4) signaling cascade in vascular remodeling. Circ Res 90:340-7, 2002.
Adult Somatic Cells
Christman KL, Vardanian AJ, Fang Q, et al. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol 2004;44:654–60.
Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. Clin Invest 2005;115:572–83.
Fazel S, Tang GH, Angoulvant D, et al. Current status of cellular therapy for ischemic heart disease. Ann Thorac Surg 2005;79:S2238–47.
Maurel A, Azarnoush K, Sabbah L, et al. Can cold or heat shock improve skeletal myoblast engraftment in infarcted myocardium? Transplantation 2005;5;80:660–5.
Melo LG, Pachori AS, Kong D, et al. Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium: reasons for cautious optimism. Circulation 2004;109:2386–93.
Murry CE, Field LJ, Menasche P. Cell-based cardiac repair: reflections at the 10-year point. Circulation 2005;112:3174–83.
Murry CE, Wiseman RW, Schwartz SM, et al. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 1996;98:2512–23.
Ott HC, Bonaros N, Marksteiner R, et al. Combined transplantation of skeletal myoblasts and bone marrow stem cells for myocardial repair in rats. Eur J Cardio-thorac Surg 2004;25:627–34.
Reinecke H, Poppa V, Murry CE. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 2002;34:241–9.
Sanchez PL, San Roman JA, Villa A, et al. Contemplating the bright future of stem cell therapy for cardiovascular disease. Nat Clin Pract Cardiovasc Med 2006;(Suppl 1):S138–51.
Suzuki K, Murtuza B, Beauchamp JR, et al. Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J 2004;18:1153–5.
Taylor DA, Atkins BZ, Hungspreugs P, et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998;4:929–33. Erratum in: Nat Med 1998;4:1200.
Yau TM, Kim C, Ng D, et . . .
Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. Clin Invest 2005;115:572–83.
Fazel S, Tang GH, Angoulvant D, et al. Current status of cellular therapy for ischemic heart disease. Ann Thorac Surg 2005;79:S2238–47.
Maurel A, Azarnoush K, Sabbah L, et al. Can cold or heat shock improve skeletal myoblast engraftment in infarcted myocardium? Transplantation 2005;5;80:660–5.
Melo LG, Pachori AS, Kong D, et al. Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium: reasons for cautious optimism. Circulation 2004;109:2386–93.
Murry CE, Field LJ, Menasche P. Cell-based cardiac repair: reflections at the 10-year point. Circulation 2005;112:3174–83.
Murry CE, Wiseman RW, Schwartz SM, et al. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 1996;98:2512–23.
Ott HC, Bonaros N, Marksteiner R, et al. Combined transplantation of skeletal myoblasts and bone marrow stem cells for myocardial repair in rats. Eur J Cardio-thorac Surg 2004;25:627–34.
Reinecke H, Poppa V, Murry CE. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 2002;34:241–9.
Sanchez PL, San Roman JA, Villa A, et al. Contemplating the bright future of stem cell therapy for cardiovascular disease. Nat Clin Pract Cardiovasc Med 2006;(Suppl 1):S138–51.
Suzuki K, Murtuza B, Beauchamp JR, et al. Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J 2004;18:1153–5.
Taylor DA, Atkins BZ, Hungspreugs P, et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998;4:929–33. Erratum in: Nat Med 1998;4:1200.
Yau TM, Kim C, Ng D, et . . .